FDA NDC Directory · JSON-LD · Markdown
NDC 51662-1555 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION
| Labeler / Manufacturer | HF Acquisition Co LLC, DBA HealthFirst |
|---|---|
| Marketing category | Biologic License Application · App BLA021859 |
| Dosage form / route | INJECTION, SOLUTION · SUBCUTANEOUS |
| Active ingredients | HYALURONIDASE (HUMAN RECOMBINANT) (150 [USP'U]/mL) |
| Marketing started | 20210604 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).